echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Wuhan University, Zhongnan Hospital PNAS issued a paper: New progress of human V-ATPase and mTOR

    Wuhan University, Zhongnan Hospital PNAS issued a paper: New progress of human V-ATPase and mTOR

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the Proceedings of the National Academy of Sciences of the United States of America (PNAS) published online the research on human V-ATPase and mTOR by Wang Longfei, a professor at the School of Pharmacy of Wuhan University and the Institute of Pharmacy of Zhongnan Hospital.


    The title of the paper is "Identification of mEAK-7 as a human V-ATPase regulator via cryo-EM data mining"


    Studies have shown that V-ATPases mediate many important signal transduction processes, including Wnt, mTOR, and Notch, etc.


    To identify V-ATPase binding partners, the authors performed multiple rounds of classification and focused refinement based on a large cryo-electron microscopy dataset of human V-ATPase purified from HEK293 cells


    This study lays the foundation for future studies on the role of mEAK-7 in mTOR signaling and V-ATPase regulation


    The structure and interaction of mEAK-7 and V-ATPase

    Wang Longfei's research group has been engaged in structural pharmacology research for a long time, mainly focusing on important targets of innate immunity and inflammation, as well as the interaction between pathogenic microorganisms and the host.


    Paper link: https://doi.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.